7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          The blood-brain barrier (BBB) provides a constant homeostatic brain environment that is essential for proper neural function. An unusually low rate of vesicular transport (transcytosis) has been identified as one of the two unique properties of central nervous system (CNS) endothelial cells, relative to peripheral endothelial cells, that maintain the restrictive quality of the BBB. However, it is not known how this low rate of transcytosis is achieved. Here we provide a mechanism whereby the regulation of CNS endothelial cell lipid composition inhibits specifically the caveolae-mediated transcytotic route readily used in the periphery. An unbiased lipidomic analysis reveals significant differences in endothelial cell lipid signatures from the CNS and periphery, which underlie a suppression of caveolae vesicle formation and trafficking in brain endothelial cells. Furthermore, lipids transported by Mfsd2a establish a unique lipid environment that inhibits caveolae vesicle formation in CNS endothelial cells to suppress transcytosis and ensure BBB integrity.

          Related collections

          Author and article information

          Journal
          8809320
          1600
          Neuron
          Neuron
          Neuron
          0896-6273
          1097-4199
          12 April 2017
          13 April 2017
          03 May 2017
          03 May 2018
          : 94
          : 3
          : 581-594.e5
          Affiliations
          [1 ]Department of Neurobiology, Harvard Medical School, 220 Longwood Ave, Boston, MA 02115, U.S.A
          [2 ]Howard Hughes Medial Institute, Harvard Medical School, Boston, MA, U.S.A
          [3 ]Broad Institute of MIT and Harvard, Cambridge, MA, 02142, U.S.A
          Author notes
          Correspondence and requests for materials should be addressed to: Chenghua Gu, ( chenghua_gu@ 123456hms.harvard.edu ), Department of Neurobiology, Harvard Medical School Boston, MA 02115, U.S.A., (Ph) 617-432-6364 (Fax) 617-432-1639
          [4]

          Present address: Department of Cellular & Molecular Medicine, The University of Ottawa Brain and Mind Research Institute, Ottawa, Canada.

          [5]

          Present address: Department of Developmental Biology and Cancer Research. The Hebrew University-Hadassah Medical School, Jerusalem, Israel.

          [6]

          Lead Contact.

          Article
          PMC5474951 PMC5474951 5474951 nihpa865093
          10.1016/j.neuron.2017.03.043
          5474951
          28416077
          e8130d74-62c8-4f74-9b26-a5b552491295
          History
          Categories
          Article

          blood-brain barrier,transcytosis,CNS endothelial cells,caveolae,DHA,lipid transport,Mfsd2a,Cav-1,blood vessels,lipidomic mass spectrometry

          Comments

          Comment on this article